Shenzhen Historical Balance Sheet

300942 Stock

9.88 0.74 6.97%

Trend analysis of Shenzhen Bioeasy Biotechnology balance sheet accounts such as Total Current Liabilities of 111.1 M, Total Stockholder Equity of 655.8 M or Retained Earnings of 209 M provides information on Shenzhen Bioeasy's total assets, liabilities, and equity, which is the actual value of Shenzhen Bioeasy Bio to its prevalent stockholders. By breaking down trends over time using Shenzhen Bioeasy balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Shenzhen Bioeasy Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shenzhen Bioeasy Bio is a good buy for the upcoming year.

Shenzhen Bioeasy Inventory

55.87 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Bioeasy Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Shenzhen Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Shenzhen Bioeasy Bio at a specified time, usually calculated after every quarter, six months, or one year. Shenzhen Bioeasy Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Shenzhen Bioeasy and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Shenzhen currently owns. An asset can also be divided into two categories, current and non-current.

Shenzhen Bioeasy Balance Sheet Chart

At present, Shenzhen Bioeasy's Retained Earnings are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 50.3 M, whereas Total Assets are forecasted to decline to about 869.7 M.

Total Assets Total Current Liabilities Total Stockholder Equity Retained Earnings Intangible Assets

Total Assets

Total assets refers to the total amount of Shenzhen Bioeasy assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Shenzhen Bioeasy Bio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Shenzhen Bioeasy balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Shenzhen Bioeasy Biotechnology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Intangible Assets

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

Most accounts from Shenzhen Bioeasy's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Shenzhen Bioeasy Bio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Bioeasy Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Total Current Liabilities	156.6M	199.8M	136.9M	111.1M
Total Assets	1.2B	1.3B	1.4B	869.7M

Total Current Liabilities Total Assets

Shenzhen Bioeasy balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Capital Surpluse	Inventory	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Other Current Liab	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Other Stockholder Equity	Net Invested Capital	Capital Stock
Total Assets		0.97	0.99	0.86	0.83	0.91	0.99	0.93	0.95	0.79	0.82	0.53	0.82	0.96	-0.82	0.9	0.94	0.93	-0.9	0.94	0.91	0.46	0.66	-0.86	0.93	0.85
Total Current Liabilities	0.97		0.98	0.92	0.7	0.89	0.94	0.92	0.89	0.79	0.91	0.68	0.75	0.92	-0.78	0.89	0.88	0.91	-0.87	0.92	0.89	0.6	0.55	-0.87	0.89	0.76
Total Stockholder Equity	0.99	0.98		0.93	0.83	0.89	0.98	0.97	0.96	0.75	0.89	0.53	0.76	0.98	-0.86	0.91	0.95	0.91	-0.9	0.89	0.85	0.54	0.57	-0.83	0.87	0.77
Retained Earnings	0.86	0.92	0.93		0.67	0.78	0.85	0.93	0.84	0.65	0.97	0.53	0.55	0.92	-0.79	0.83	0.84	0.79	-0.81	0.74	0.65	0.77	0.33	-0.74	0.71	0.54
Cash	0.83	0.7	0.83	0.67		0.72	0.86	0.88	0.94	0.5	0.58	0.13	0.68	0.89	-0.88	0.75	0.93	0.71	-0.76	0.66	0.62	0.14	0.6	-0.53	0.66	0.68
Other Assets	0.91	0.89	0.89	0.78	0.72		0.85	0.82	0.83	0.87	0.77	0.41	0.92	0.86	-0.72	0.9	0.81	0.98	-0.96	0.93	0.89	0.33	0.81	-0.88	0.93	0.9
Cash And Short Term Investments	0.99	0.94	0.98	0.85	0.86	0.85		0.94	0.96	0.73	0.79	0.48	0.75	0.96	-0.83	0.87	0.96	0.87	-0.85	0.9	0.86	0.48	0.58	-0.81	0.89	0.81
Net Receivables	0.93	0.92	0.97	0.93	0.88	0.82	0.94		0.95	0.69	0.86	0.42	0.69	0.99	-0.92	0.84	0.94	0.84	-0.83	0.79	0.72	0.53	0.51	-0.75	0.78	0.68
Common Stock Shares Outstanding	0.95	0.89	0.96	0.84	0.94	0.83	0.96	0.95		0.6	0.79	0.4	0.73	0.96	-0.86	0.88	1.0	0.83	-0.87	0.8	0.77	0.39	0.58	-0.69	0.79	0.73
Capital Surpluse	0.79	0.79	0.75	0.65	0.5	0.87	0.73	0.69	0.6		0.61	0.41	0.88	0.7	-0.62	0.66	0.57	0.92	-0.73	0.9	0.84	0.29	0.79	-0.94	0.91	0.89
Inventory	0.82	0.91	0.89	0.97	0.58	0.77	0.79	0.86	0.79	0.61		0.64	0.52	0.85	-0.73	0.86	0.79	0.75	-0.83	0.71	0.66	0.77	0.29	-0.69	0.67	0.48
Other Current Assets	0.53	0.68	0.53	0.53	0.13	0.41	0.48	0.42	0.4	0.41	0.64		0.34	0.37	-0.35	0.46	0.41	0.44	-0.41	0.52	0.65	0.46	0.15	-0.49	0.48	0.28
Total Liab	0.82	0.75	0.76	0.55	0.68	0.92	0.75	0.69	0.73	0.88	0.52	0.34		0.72	-0.64	0.7	0.69	0.94	-0.8	0.89	0.89	0.0	0.96	-0.86	0.91	0.95
Total Current Assets	0.96	0.92	0.98	0.92	0.89	0.86	0.96	0.99	0.96	0.7	0.85	0.37	0.72		-0.88	0.88	0.96	0.87	-0.87	0.83	0.75	0.53	0.55	-0.78	0.82	0.74
Short Term Debt	-0.82	-0.78	-0.86	-0.79	-0.88	-0.72	-0.83	-0.92	-0.86	-0.62	-0.73	-0.35	-0.64	-0.88		-0.75	-0.85	-0.72	0.76	-0.64	-0.62	-0.32	-0.5	0.57	-0.64	-0.59
Intangible Assets	0.9	0.89	0.91	0.83	0.75	0.9	0.87	0.84	0.88	0.66	0.86	0.46	0.7	0.88	-0.75		0.88	0.84	-0.98	0.83	0.8	0.5	0.54	-0.69	0.81	0.72
Common Stock	0.94	0.88	0.95	0.84	0.93	0.81	0.96	0.94	1.0	0.57	0.79	0.41	0.69	0.96	-0.85	0.88		0.8	-0.85	0.79	0.76	0.41	0.53	-0.67	0.78	0.71
Property Plant Equipment	0.93	0.91	0.91	0.79	0.71	0.98	0.87	0.84	0.83	0.92	0.75	0.44	0.94	0.87	-0.72	0.84	0.8		-0.9	0.96	0.91	0.34	0.82	-0.95	0.96	0.92
Other Current Liab	-0.9	-0.87	-0.9	-0.81	-0.76	-0.96	-0.85	-0.83	-0.87	-0.73	-0.83	-0.41	-0.8	-0.87	0.76	-0.98	-0.85	-0.9		-0.85	-0.82	-0.4	-0.67	0.74	-0.84	-0.78
Accounts Payable	0.94	0.92	0.89	0.74	0.66	0.93	0.9	0.79	0.8	0.9	0.71	0.52	0.89	0.83	-0.64	0.83	0.79	0.96	-0.85		0.96	0.38	0.76	-0.95	1.0	0.94
Non Current Assets Total	0.91	0.89	0.85	0.65	0.62	0.89	0.86	0.72	0.77	0.84	0.66	0.65	0.89	0.75	-0.62	0.8	0.76	0.91	-0.82	0.96		0.26	0.77	-0.88	0.96	0.9
Non Currrent Assets Other	0.46	0.6	0.54	0.77	0.14	0.33	0.48	0.53	0.39	0.29	0.77	0.46	0.0	0.53	-0.32	0.5	0.41	0.34	-0.4	0.38	0.26		-0.25	-0.43	0.32	0.08
Non Current Liabilities Total	0.66	0.55	0.57	0.33	0.6	0.81	0.58	0.51	0.58	0.79	0.29	0.15	0.96	0.55	-0.5	0.54	0.53	0.82	-0.67	0.76	0.77	-0.25		-0.73	0.8	0.91
Other Stockholder Equity	-0.86	-0.87	-0.83	-0.74	-0.53	-0.88	-0.81	-0.75	-0.69	-0.94	-0.69	-0.49	-0.86	-0.78	0.57	-0.69	-0.67	-0.95	0.74	-0.95	-0.88	-0.43	-0.73		-0.95	-0.88
Net Invested Capital	0.93	0.89	0.87	0.71	0.66	0.93	0.89	0.78	0.79	0.91	0.67	0.48	0.91	0.82	-0.64	0.81	0.78	0.96	-0.84	1.0	0.96	0.32	0.8	-0.95		0.96
Capital Stock	0.85	0.76	0.77	0.54	0.68	0.9	0.81	0.68	0.73	0.89	0.48	0.28	0.95	0.74	-0.59	0.72	0.71	0.92	-0.78	0.94	0.9	0.08	0.91	-0.88	0.96

Click cells to compare fundamentals

Shenzhen Bioeasy Account Relationship Matchups

Shenzhen Bioeasy balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	619.7M	652.9M	1.2B	1.3B	1.4B	869.7M
Total Current Liabilities	68.1M	78.1M	156.6M	199.8M	136.9M	111.1M
Total Stockholder Equity	528.4M	549.1M	944.8M	964.9M	849.0M	655.8M
Retained Earnings	163.4M	183.8M	402.3M	331.9M	138.4M	209.0M
Cash	420.8M	374.2M	339.2M	247.5M	481.7M	337.2M
Other Assets	11.7M	10.0M	28.9M	41.6M	47.9M	50.3M
Cash And Short Term Investments	183.1M	440.8M	374.2M	679.4M	781.4M	390.9M
Net Receivables	74.2M	62.3M	97.2M	83.9M	76.1M	73.0M
Liabilities And Stockholders Equity	296.8M	619.7M	652.9M	1.2B	1.3B	1.4B
Inventory	31.3M	61.6M	93.9M	100.6M	31.5M	55.9M
Other Current Assets	5.3M	4.9M	3.0M	213.3M	12.0M	11.4M
Total Liab	91.3M	103.8M	207.8M	317.8M	507.6M	533.0M
Total Current Assets	569.7M	526.1M	897.6M	674.4M	737.7M	600.8M
Intangible Assets	1.4M	44.1M	42.6M	42.4M	41.4M	27.2M
Property Plant Equipment	15.7M	29.4M	44.9M	143.4M	165.0M	173.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Shenzhen Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shenzhen Historical Balance Sheet

Shenzhen Bioeasy Inventory

55.87 Million

About Shenzhen Balance Sheet Analysis

Shenzhen Bioeasy Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Retained Earnings

Intangible Assets

Shenzhen Bioeasy balance sheet Correlations

Shenzhen Bioeasy Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shenzhen Bioeasy balance sheet Accounts

Also Currently Popular

Other Information on Investing in Shenzhen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Shares Outstanding
Net Invested Capital	+ 1.0	Accounts Payable
Total Stockholder Equity	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Net Receivables
Total Stockholder Equity	+ 0.98	Total Current Liabilities

Other Current Liab	- 0.98	Intangible Assets
Other Current Liab	- 0.96	Other Assets
Net Invested Capital	- 0.95	Other Stockholder Equity
Other Stockholder Equity	- 0.95	Accounts Payable
Other Stockholder Equity	- 0.95	Property Plant Equipment
Other Stockholder Equity	- 0.94	Capital Surpluse